• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND ALINITY I HBSAG QUALITATIVE II REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND ALINITY I HBSAG QUALITATIVE II REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM) Back to Search Results
Catalog Number 08P10-32
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/27/2022
Event Type  malfunction  
Event Description
The customer observed false reactive alinity i hbsag qualitative ii and alinity i hbsag qualitative ii confirmatory results for a 69-year-old female dialysis patient with chronic kidney disease.A second sample was requested, and the result was still reactive.The patient went to another laboratory which generated a nonreactive result.A third sample was drawn from the patient and the result was nonreactive.The following data was provided: (b)(6) 2022 sid (b)(6) result (ai02993) = 3.38 s/co (reactive) sample was recentrifuged and repeated on ai02759 = 3.67 s/co (reactive) neutralization confirmatory results: c2= 3.00 s/co, %neutralization = 99% (confirmed positive) 2nd sample result (ai02759) = 3.00 s/co (reactive), did not repeat or perform confirmatory 3rd sample drawn (b)(6) 2022 result (ai02759) = 0.28 s/co (nonreactive) hbsag result at another laboratory (electrochemiluminescence method) = nonreactive no impact to patient management was reported.
 
Manufacturer Narrative
This report is being filed on an international product, list number 8p10-32 that has a similar product distributed in the us, list number 8p10-21/-31.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Manufacturer Narrative
The complaint investigation for false reactive alinity i hbsag qualitative ii results included a review of data and information provided by the customer, search for similar complaints, ticket trending review, device history record review, field data review and labeling review.Return testing was not completed as returns were not available.Data and information provided by the customer were reviewed and support the complaint issue.Ticket search by lot indicates that the reagent lot performs as expected for this product.Trending review did not identify any trends for the issue for the product.Device history record review did not identify any non-conformances or deviations with lot 34461fn00 and complaint issue.The historical performance of the alinity i hbsag qualitative ii reagent was reviewed using field data from customers worldwide.The median patient result for lot 34461fn00 is within the established baseline, indicating the reagent lot is comparable with other lots in the field, confirming no systemic issue for the lot.Labeling was reviewed and sufficiently addresses the customer's issue.Based on our investigation, no systemic issue or deficiency with the alinity i hbsag qualitative ii reagent for lot 34461fn00 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I HBSAG QUALITATIVE II REAGENT KIT
Type of Device
TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)
Manufacturer (Section D)
ABBOTT IRELAND
finisklin business park
sligo F91VY 44
EI  F91VY44
Manufacturer (Section G)
ABBOTT IRELAND
finisklin business park
sligo F91VY 44
EI   F91VY44
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
EI   N39 E932
433331157
MDR Report Key15426953
MDR Text Key302166180
Report Number3008344661-2022-00110
Device Sequence Number1
Product Code LOM
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
P110029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/18/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/15/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/13/2022
Device Catalogue Number08P10-32
Device Lot Number34461FN00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/28/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/23/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY I PROCESSING MODU,03R65-01,(B)(6); ALNTY I PROCESSING MODU,03R65-01,(B)(6); ALNTY I PROCESSING MODU,03R65-01,(B)(6); ALNTY I PROCESSING MODU,03R65-01,(B)(6)
Patient Age69 YR
Patient SexFemale
-
-